Immunotherapy utilization in stage IIIA melanoma: less may be more.
Frey AE, Kerekes DM, Khan SA, Tran TT, Kluger HM, Clune JE, Ariyan S, Sznol M, Ishizuka JJ, Olino KL.
Frey AE, et al. Among authors: olino kl.
Front Oncol. 2024 Feb 6;14:1336441. doi: 10.3389/fonc.2024.1336441. eCollection 2024.
Front Oncol. 2024.
PMID: 38380358
Free PMC article.